Molecular insights of the G2019S substitution in LRRK2 kinase domain associated with Parkinson's disease: A molecular dynamics simulation approach

被引:30
作者
Agrahari, Ashish Kumar [1 ]
Doss, George Priya C. [1 ]
Siva, R. [1 ]
Magesh, R. [2 ]
Zayed, Hatem [3 ]
机构
[1] VIT, Sch Biosci & Technol, Dept Integrat Biol, Vellore 632014, Tamil Nadu, India
[2] DU, SRIHER, Dept Biotechnol, Chennai 600116, Tamil Nadu, India
[3] Qatar Univ, Coll Hlth & Sci, Dept Biomed Sci, Doha, Qatar
关键词
PD; LRRK2; Kinase domain; G2019S; DYG; Molecular dynamics simulation; MUTATIONAL ANALYSIS; PROTEIN; IMPACT; MECHANISMS; GENE; GTPASE; MODEL;
D O I
10.1016/j.jtbi.2019.03.003
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The G2019S substitution in the Leucine-rich repeat kinase 2 (LRRK2) is significantly associated with Parkinson's disease (PD). This substitution was identified in both familial and sporadic forms of PD with a higher frequency. Few computational studies have reported the impact of G2019S substitution on inhibitors of the kinase domain of LRRK2. However, no computational study deeply investigated the possible impact of the G2019S substitution on the kinase domain in its Apo conformation. Therefore, in this study, we used 200 ns molecular dynamic simulation using the GROMACS 5.1.4 package software to investigate the impact of the G2019S substitution on the structure of the kinase domain of LRRK2. Our results indicate that the G2019S substitution affects the dynamics and stability of LRRK2 by decreasing the flexibility and increasing the compactness of the kinase domain and showing its tendency to be in an active conformation for long time interval because of the high energy barrier between active and inactive conformation. This study predicts the molecular pathogenicity mechanism of the G2019S on patients with PD and provides a potential platform for developing therapeutics for patients with PD that harbor this amino acid substitution. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页码:163 / 171
页数:9
相关论文
共 50 条
  • [41] The Parkinson's disease-associated mutation N1437H impairs conformational dynamics in the G domain of LRRK2
    Huang, Xiaorong
    Wu, Chunxiang
    Park, Yangshin
    Long, Xuwei
    Hoang, Quyen Q.
    Liao, Jingling
    FASEB JOURNAL, 2019, 33 (04) : 4814 - 4823
  • [42] Olfactory Deficits and Cardiac 123I-MIBG in Parkinson's Disease Related to the LRRK2 R1441G and G2019S Mutations
    Ruiz-Martinez, Javier
    Gorostidi, Ana
    Goyenechea, Estibaliz
    Alzualde, Ainhoa
    Jose Poza, Juan
    Rodriguez, Francisco
    Bergareche, Alberto
    Moreno, Fermin
    Lopez de Munain, Adolfo
    Marti Masso, Jose F.
    MOVEMENT DISORDERS, 2011, 26 (11) : 2026 - 2031
  • [43] Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease
    Seol, Wongi
    BMB REPORTS, 2010, 43 (04) : 233 - 244
  • [44] Increased frequency of the LRRK2 G2019S mutation in an elderly Ashkenazi Jewish population is not associated with dementia
    Saunders-Pullman, Rachel
    Lipton, Richard B.
    Senthil, Geetha
    Katz, Mindy
    Costan-Toth, Camille
    Derby, Carol
    Bressman, Susan
    Verghese, Joe
    Ozelius, Laurie J.
    NEUROSCIENCE LETTERS, 2006, 402 (1-2) : 92 - 96
  • [45] How Parkinson's disease-related mutations disrupt the dimerization of WD40 domain in LRRK2: a comparative molecular dynamics simulation study
    Li, Xinyi
    Ye, Mingyu
    Wang, Yue
    Qiu, Ming
    Fu, Tingting
    Zhang, Jian
    Zhou, Bin
    Lu, Shaoyong
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2020, 22 (36) : 20421 - 20433
  • [46] The LRRK2 R1441C Mutation is More Frequent Than G2019S in Parkinson's Disease Patients from Southern Italy
    Criscuolo, Chiara
    De Rosa, Anna
    Guacci, Anna
    Simons, Erik J.
    Breedveld, Guido J.
    Peluso, Silvio
    Volpe, Giampiero
    Filla, Alessandro
    Oostra, Ben A.
    Bonifati, Vincenzo
    De Michele, Giuseppe
    MOVEMENT DISORDERS, 2011, 26 (09) : 1733 - 1736
  • [47] Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson's disease
    Gonzalez-Hunt, C. P.
    Thacker, E. A.
    Toste, C. M.
    Boularand, S.
    Deprets, S.
    Dubois, L.
    Sanders, L. H.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [48] The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
    Cookson, Mark R.
    NATURE REVIEWS NEUROSCIENCE, 2010, 11 (12) : 791 - 797
  • [49] Parkin Protects against LRRK2 G2019S Mutant-Induced Dopaminergic Neurodegeneration in Drosophila
    Ng, Chee-Hoe
    Mok, Shaun Z. S.
    Koh, Cherlyn
    Ouyang, Xuezhi
    Fivaz, Marc L.
    Tan, Eng-King
    Dawson, Valina L.
    Dawson, Ted M.
    Yu, Fengwei
    Lim, Kah-Leong
    JOURNAL OF NEUROSCIENCE, 2009, 29 (36) : 11257 - 11262
  • [50] Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease
    Ben Sassi, Samia
    Nabli, Fatma
    Hentati, Emna
    Nahdi, Houda
    Trabelsi, Meriam
    Ben Ayed, Hela
    Amouri, Rim
    Duda, John Eric
    Farrer, Matthew John
    Hentati, Faycal
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (03) : 243 - 246